Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page metadata revision was updated from v3.6.3 to v3.6.4. This reflects a new release version of the page's documentation.
    Difference
    0.0%
    Check dated 2026-07-24T02:44:55.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new site in Vinnytsia, Ukraine (Site 8002) and the associated investigator were added, increasing the total number of locations to 429. The inclusion/eligibility language for KAR-033 was expanded to specify consent procedures, assent, and relocation considerations.
    Difference
    0.3%
    Check dated 2026-07-09T16:58:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.6.3) replacing the older label (v3.6.1). This indicates a small release update to the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-02T14:23:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.1 replaces v3.6.0 on the page, indicating a small administrative update to the documentation. The substantive content and behavior remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-25T10:54:45.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The ADEPT-3 study location footprint was updated to 428 locations with two new sites added (Bucharest, Romania and Xi’an, China) and the total locations increased accordingly. Additionally, several existing sites were removed, indicating adjustments to where participants may enroll.
    Difference
    0.6%
    Check dated 2026-06-18T07:29:44.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    New user guidance links were added to the page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was standardized and the page revision updated from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-11T03:46:31.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.